Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study | Zendy

Luther A. Bartelt | Zendy; Alena J. Markmann | Zendy; Bridget Nelson | Zendy; Jessica Keys | Zendy; Heather Root | Zendy; Heather Henderson | Zendy; JoAnn Kuruc | Zendy; Caroline Baker | Zendy; D. Ryan Bhowmik | Zendy; Yixuan J. Hou | Zendy; Lakshmanane Premkumar | Zendy; Caleb Cornaby | Zendy; John L. Schmitz | Zendy; Susan R. Weiss | Zendy; Yara Park | Zendy; Ralph S. Baric | Zendy; Aravinda M. de Silva | Zendy; Anne M. Lachiewicz | Zendy; Sonia Napravnik | Zendy; David van Duin | Zendy; David M. Margolis | Zendy

Open Access

Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study

Author(s) -

Luther A. Bartelt,

Alena J. Markmann,

Bridget Nelson,

Jessica Keys,

Heather Root,

Heather Henderson,

JoAnn Kuruc,

Caroline Baker,

D. Ryan Bhowmik,

Yixuan J. Hou,

Lakshmanane Premkumar,

Caleb Cornaby,

John L. Schmitz,

Susan R. Weiss,

Yara Park,

Ralph S. Baric,

Aravinda M. de Silva,

Anne M. Lachiewicz,

Sonia Napravnik,

David van Duin,

David M. Margolis

Publication year - 2022

Publication title -

mbio

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.562

H-Index - 121

eISSN - 2161-2129

pISSN - 2150-7511

DOI - 10.1128/mbio.01751-22

Subject(s) - convalescent plasma , covid-19 , virology , medicine , coronavirus , antibody , titer , betacoronavirus , neutralizing antibody , immunology , disease , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research